7Baggers
 Published on: 2025-10-03 01:40:17  newser.com Fri, 03 Oct 2025 06:40:17 GMT
 Published on: 2025-10-03 00:29:03  newser.com Fri, 03 Oct 2025 05:29:03 GMT
 published on: 2025-09-29 23:29:05  newser.com Tue, 30 Sep 2025 04:29:05 GMT
 Published on: 2025-09-29 15:30:24  newser.com Mon, 29 Sep 2025 20:30:24 GMT
 published on: 2025-09-29 08:13:08  newser.com Mon, 29 Sep 2025 13:13:08 GMT
 published on: 2025-09-26 03:25:10  newser.com Fri, 26 Sep 2025 08:25:10 GMT
 genenta science (nasdaq:gnta) trading down 1.9% - what's next?  MarketBeat Mon, 22 Sep 2025 07:00:00 GMT
 genenta science (nasdaq:gnta) trading down 1.9% - what's next?  MarketBeat Sun, 21 Sep 2025 00:30:32 GMT
 genenta science (nasdaq:gnta) trading down 1.9% - what's next?  MarketBeat Sat, 20 Sep 2025 07:00:00 GMT
 published on: 2025-09-19 16:11:29  خودرو بانک Fri, 19 Sep 2025 12:43:41 GMT
 genenta science (nasdaq:gnta) trading down 1.9% - should you sell?  MarketBeat Fri, 19 Sep 2025 06:02:56 GMT
 genenta science (nasdaq:gnta) shares down 1.9% - should you sell?  MarketBeat Fri, 19 Sep 2025 06:02:56 GMT
 published on: 2025-09-19 09:09:29  خودرو بانک Thu, 18 Sep 2025 17:39:25 GMT
 published on: 2025-09-16 05:59:55  خودرو بانک Mon, 15 Sep 2025 20:28:31 GMT
 published on: 2025-09-14 10:15:26  newser.com Sun, 14 Sep 2025 15:15:26 GMT
 wall street analysts are bullish on top healthcare picks  The Globe and Mail Fri, 12 Sep 2025 16:30:00 GMT
 genenta science (nasdaq:gnta) trading 7.4% higher - here's why  MarketBeat Tue, 02 Sep 2025 07:00:00 GMT

Genenta Science
(NASDAQ:GNTA) 

GNTA stock logo

Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company's lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of gliobl...

Founded: 2014
IPO Price: $11.5 (Dec 15, 2021)
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends